Several established and emerging technologies are needed by CCR investigators in order to systematically dissect the heterogeneity of cancer in order to gain a better understanding of the causes of invasion, metastasis, and therapy resistance. CCR needs to remain at the forefront of cancer research by applying the latest Single Cell (SC) technologies as they emerge rather than remaining on the sidelines. The Single Cell genomics field is rapidly evolving. Thus, CCR must continue to find ways to quickly evaluate these technologies and efficiently exploit them for ongoing research projects. These coveted technologies have been identified as having the strongest footing among the leading institutions around the world that are focused on SC genomic analysis, therefore, OSTR is dedicated to providing this groundbreaking technology to CCR investigators.